PANK4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.83380000073896E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.419410E-04 |
Normal-vs-Stage2 |
1.242740E-03 |
Normal-vs-Stage3 |
7.39386329939862E-12 |
Normal-vs-Stage4 |
3.0420999053149E-10 |
Stage1-vs-Stage2 |
3.935400E-01 |
Stage1-vs-Stage3 |
1.51626999999044E-05 |
Stage1-vs-Stage4 |
2.574700E-04 |
Stage2-vs-Stage3 |
1.105240E-01 |
Stage2-vs-Stage4 |
1.159020E-01 |
Stage3-vs-Stage4 |
9.525800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.36650024629148E-10 |
Normal-vs-AfricanAmerican |
3.079600E-01 |
Normal-vs-Asian |
5.714600E-01 |
Caucasian-vs-AfricanAmerican |
1.715510E-03 |
Caucasian-vs-Asian |
3.721300E-03 |
AfricanAmerican-vs-Asian |
3.829600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.85129997390499E-09 |
Normal-vs-Female |
4.15249999999867E-05 |
Male-vs-Female |
8.676400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.836250E-03 |
Normal-vs-Age(41-60Yrs) |
5.55009999999578E-05 |
Normal-vs-Age(61-80Yrs) |
1.68479996620619E-09 |
Normal-vs-Age(81-100Yrs) |
4.43479999945318E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.473800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.534800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.109800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.317770E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.902800E-03 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.060300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.514810E-01 |
Normal-vs-Grade 2 |
1.568230E-04 |
Normal-vs-Grade 3 |
5.09148279093097E-12 |
Normal-vs-Grade 4 |
8.29559754222942E-11 |
Grade 1-vs-Grade 2 |
1.136130E-03 |
Grade 1-vs-Grade 3 |
1.11590000018147E-07 |
Grade 1-vs-Grade 4 |
4.18069999730264E-08 |
Grade 2-vs-Grade 3 |
1.190930E-04 |
Grade 2-vs-Grade 4 |
1.621150E-04 |
Grade 3-vs-Grade 4 |
2.125400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.41680000012678E-07 |
Normal-vs-ccB subtype |
1.04489999985802E-07 |
ccA subtype-vs-ccB subtype |
1.758370E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
6.62730004208356E-09 |
Normal-vs-N1 |
8.198200E-04 |
N0-vs-N1 |
5.963200E-01 |
|
|